Annual Retained Earnings
-$206.36 M
-$99.56 M-93.22%
December 31, 2024
Summary
- As of March 12, 2025, PCRX annual retained earnings is -$206.36 million, with the most recent change of -$99.56 million (-93.22%) on December 31, 2024.
- During the last 3 years, PCRX annual retained earnings has risen by +$5.54 million (+2.61%).
- PCRX annual retained earnings is now -164.37% below its all-time high of -$78.06 million, reached on December 31, 2008.
Performance
PCRX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$206.36 M
+$16.04 M+7.21%
December 31, 2024
Summary
- As of March 12, 2025, PCRX quarterly retained earnings is -$206.36 million, with the most recent change of +$16.04 million (+7.21%) on December 31, 2024.
- Over the past year, PCRX quarterly retained earnings has stayed the same.
- PCRX quarterly retained earnings is now -161.44% below its all-time high of -$78.93 million, reached on June 30, 2024.
Performance
PCRX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
PCRX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -93.2% | 0.0% |
| 3 y3 years | +2.6% | -30.7% |
| 5 y5 years | +48.3% | -30.7% |
PCRX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -93.2% | +2.6% | -161.4% | +7.2% |
| 5 y | 5-year | -93.2% | +48.3% | -161.4% | +48.3% |
| alltime | all time | -164.4% | +48.3% | -161.4% | +48.3% |
Pacira BioSciences Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$206.36 M(+93.2%) | -$206.36 M(-7.2%) |
| Sep 2024 | - | -$222.40 M(+181.8%) |
| Jun 2024 | - | -$78.93 M(-19.3%) |
| Mar 2024 | - | -$97.82 M(-8.4%) |
| Dec 2023 | -$106.80 M(-28.2%) | -$106.80 M(-18.9%) |
| Sep 2023 | - | -$131.67 M(-7.6%) |
| Jun 2023 | - | -$142.52 M(-15.3%) |
| Mar 2023 | - | -$168.29 M(+13.1%) |
| Dec 2022 | -$148.75 M(-29.8%) | -$148.75 M(+7.3%) |
| Sep 2022 | - | -$138.65 M(+0.5%) |
| Jun 2022 | - | -$137.96 M(-12.6%) |
| Mar 2022 | - | -$157.83 M(-25.5%) |
| Dec 2021 | -$211.90 M(-16.5%) | -$211.90 M(+2.5%) |
| Sep 2021 | - | -$206.76 M(-7.9%) |
| Jun 2021 | - | -$224.43 M(-7.8%) |
| Mar 2021 | - | -$243.51 M(-4.1%) |
| Dec 2020 | -$253.88 M(-36.4%) | -$253.88 M(-5.4%) |
| Sep 2020 | - | -$268.39 M(-32.7%) |
| Jun 2020 | - | -$398.51 M(+1.9%) |
| Mar 2020 | - | -$391.24 M(-2.0%) |
| Dec 2019 | -$399.40 M(+2.9%) | -$399.40 M(+1.2%) |
| Sep 2019 | - | -$394.51 M(+1.6%) |
| Jun 2019 | - | -$388.42 M(-0.7%) |
| Mar 2019 | - | -$391.15 M(+0.8%) |
| Dec 2018 | -$388.23 M(-0.2%) | -$388.23 M(-2.1%) |
| Sep 2018 | - | -$396.51 M(+0.2%) |
| Jun 2018 | - | -$395.87 M(-0.6%) |
| Mar 2018 | - | -$398.45 M(+2.4%) |
| Dec 2017 | -$389.14 M | -$389.14 M(-1.2%) |
| Sep 2017 | - | -$393.73 M(+2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | -$386.13 M(+5.4%) |
| Mar 2017 | - | -$366.39 M(+5.8%) |
| Dec 2016 | -$346.24 M(+12.3%) | -$346.24 M(+1.2%) |
| Sep 2016 | - | -$342.27 M(+6.9%) |
| Jun 2016 | - | -$320.10 M(+2.5%) |
| Mar 2016 | - | -$312.14 M(+1.3%) |
| Dec 2015 | -$308.29 M(-0.6%) | -$308.29 M(+0.8%) |
| Sep 2015 | - | -$305.79 M(-1.0%) |
| Jun 2015 | - | -$308.88 M(-0.0%) |
| Mar 2015 | - | -$308.88 M(-0.4%) |
| Dec 2014 | -$310.14 M(+4.6%) | -$310.14 M(-1.8%) |
| Sep 2014 | - | -$315.95 M(+1.0%) |
| Jun 2014 | - | -$312.94 M(+1.6%) |
| Mar 2014 | - | -$307.91 M(+3.9%) |
| Dec 2013 | -$296.43 M(+27.5%) | -$296.43 M(+4.2%) |
| Sep 2013 | - | -$284.47 M(+5.5%) |
| Jun 2013 | - | -$269.69 M(+5.5%) |
| Mar 2013 | - | -$255.66 M(+10.0%) |
| Dec 2012 | -$232.52 M(+29.0%) | -$232.52 M(+7.6%) |
| Sep 2012 | - | -$216.17 M(+7.9%) |
| Jun 2012 | - | -$200.43 M(+4.3%) |
| Mar 2012 | - | -$192.13 M(+6.6%) |
| Dec 2011 | -$180.24 M(+31.6%) | -$180.24 M(+9.3%) |
| Sep 2011 | - | -$164.96 M(+6.1%) |
| Jun 2011 | - | -$155.45 M(+6.0%) |
| Mar 2011 | - | -$146.69 M(+7.1%) |
| Dec 2010 | -$136.91 M(+24.7%) | -$136.91 M(+5.4%) |
| Sep 2010 | - | -$129.87 M(+7.3%) |
| Jun 2010 | - | -$121.06 M(+10.3%) |
| Dec 2009 | -$109.76 M(+40.6%) | -$109.76 M |
| Dec 2008 | -$78.06 M | - |
FAQ
- What is Pacira BioSciences annual retained earnings?
- What is the all time high annual retained earnings for Pacira BioSciences?
- What is Pacira BioSciences annual retained earnings year-on-year change?
- What is Pacira BioSciences quarterly retained earnings?
- What is the all time high quarterly retained earnings for Pacira BioSciences?
- What is Pacira BioSciences quarterly retained earnings year-on-year change?
What is Pacira BioSciences annual retained earnings?
The current annual retained earnings of PCRX is -$206.36 M
What is the all time high annual retained earnings for Pacira BioSciences?
Pacira BioSciences all-time high annual retained earnings is -$78.06 M
What is Pacira BioSciences annual retained earnings year-on-year change?
Over the past year, PCRX annual retained earnings has changed by -$99.56 M (-93.22%)
What is Pacira BioSciences quarterly retained earnings?
The current quarterly retained earnings of PCRX is -$206.36 M
What is the all time high quarterly retained earnings for Pacira BioSciences?
Pacira BioSciences all-time high quarterly retained earnings is -$78.93 M
What is Pacira BioSciences quarterly retained earnings year-on-year change?
Over the past year, PCRX quarterly retained earnings has changed by $0.00 (0.00%)